Description
Dolasetronisanantiemeticthatisclinicallyusedtopreventchemotherapy-inducednauseaandemesis.DolasetronactsasanantagoNISTat5-HT3receptors.
Dolasetronisanantiemeticthatisclinicallyusedtopreventchemotherapy-inducednauseaandemesis.DolasetronactsasanantagoNISTat5-HT3receptors.
| CasNo. | 115956-12-2 |
|---|---|
| Purity | ≥98% |
| Formula | C19H20N2O3 |
| FormulaWt. | 324.37 |
| Solubility | Solubleinwaterandethanol. |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | D5746MSDSPDF |
|---|---|
| InfoSheet | D5746InfoSheetPDF |
HsuES.Areviewofgranisetron,5-hydroxytryptamine3receptorantagonists,andotherantiemetics.AmJTher.2010Sep-Oct;17(5):476-86.PMID:20844345.
BirminghamSD,MecklenburgBW,LujanE,etal.Dolasetronversusondansetronassingle-agentprophylaxisforpatientsatincreasedriskforpostoperativenauseaandvomiting:aProspective,double-blind,randomizedtrial.MilMed.2006Sep;171(9):913-6.PMID:17036618.